Yh. Samaranayake et al., THE ANTIFUNGAL EFFECT OF LACTOFERRIN AND LYSOZYME ON CANDIDA-KRUSEI AND CANDIDA-ALBICANS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(11), 1997, pp. 875-883
Lactoferrin and lysozyme (muramidase) are non-immune defence factors p
resent in various exocrine secretions, including saliva. Previous stud
ies have shown that both proteins, either singly or in combination, ar
e bactericidal in nature and their combined activity is synergistic. A
s little is known of their interactions with Candida species, 20 oral
isolates of C. krusei and 5 isolates of C. albicans were studied for t
heir susceptibility to human apo-lactoferrin and lysozyme, either sing
ly or in combination, using an in vitro assay system. The two species
exhibited significant interspecies differences in susceptibility to la
ctoferrin (p<0.05), but not for lysozyme; C. krusei being more sensiti
ve to lactoferrin (c 1.4 times) than C. albicans. Both species reveale
d significant intraspecies differences in their susceptibility to lyso
zyme (p<0.05), but not for lactoferrin. No synergistic antifungal acti
vity of the two proteins on either Candida species was noted. The resu
lts imply that the variable expression of the fungicidal activity of l
actoferrin and lysozyme on Candida species may modulate the oral carri
age of yeasts in a complex manner.